IMRIS intraoperative imaging solutions provide optimized visualization platform for emerging neurosurgical therapies

Learn more about these state-of-the-art products at CNS annual meeting

MINNEAPOLIS, Oct. 9, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that use of intraoperative imaging for optimizing workflow with neurosurgical focal therapies will be featured in its exhibition space at the Congress of Neurosurgical Surgeons (CNS) meeting in Boston from Oct. 20-22. IMRIS invites meeting attendees to visit booth 442.

Emerging focal therapies such as laser ablation and neuro-navigation combined with intraoperative MRI in the VISIUS Surgical Theatre allow for expanding minimally invasive techniques and accurate placement of tools for improved outcomes. IMRIS products provide surgeons on-demand access to real-time, state-of-the-art imaging during procedures in the operating room (OR) without moving the patient. VISIUS Surgical Theatres by IMRIS are equipped with either high-field MR or 64-slice computed tomography (CT) that move to the patient on ceiling-mounted rails.

"We continue to develop and put into the hands of neurosurgeons cutting edge visualization which support these growing less invasive treatment options for improving patient outcomes," said Jay D. Miller, IMRIS President and CEO. "In some of these cases, these innovations are offering patients new hope for conditions once considered inoperable. The VISIUS Surgical Theatre is an ideal platform for neurosurgeons by enabling therapies in the OR with enhanced surgical planning and assessment without moving the patient."

IMRIS also designs and manufactures proprietary head fixation devices, horseshoe headrests, imaging coils, and OR tables for use in this unique and multifunctional intraoperative environment.

About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets and have been selected by 61 leading medical institutions around the world.

SOURCE IMRIS Inc.